However, this does not mean that there are not promising treatments already in practice or on the horizon that can combat mesothelioma or lung cancer and increase your chances of survival and quality of life.
Treatments that have not been fully researched are known as emerging treatments, and there are a number of effective emerging treatments that mesothelioma patients should be aware of.
Multimodal therapy is one of the most aggressive, effective forms of mesothelioma treatments to date and is increasing in use for cases across the country.
This form of emerging treatment combines two or more treatment methods to attack the cancer cells from all possible angles.
Most forms of multimodal therapy use a three-pronged approach. Surgery, radiation, and chemotherapy.
The main purpose of a multimodal approach is to increase survival rates and improve a patient’s quality of life by removing and shrinking tumors as much as possible.
Although its effectiveness in mesothelioma cases is still undergoing trials, one emerging therapy currently under use is called cryotherapy or cryoablation.
Cryotherapy works to eliminate cancerous tumors through the use of extreme, hypothermic cold. No living tissue, including cancerous cells, can survive cold temperatures once they reach a certain threshold.
Cryotherapy uses this biological advantage to attack and kill tumors in a wide variety of cancer patients.
Not all emerging treatment therapies are ready to be used for actual patients, still in the experimental stage where the efficacy and side-effects are being examined.
One such therapy that may provide extremely useful for mesothelioma patients is gene therapy.
Gene therapy works through the manipulation of a patient’s genes in order to prevent or reverse certain terminal diseases.
Gene therapy has already shown promise in treating such genetic conditions as severe combined immune deficiency and is preparing to enter the clinical trial stage for mesothelioma where researchers hope to be able to target defective genes that lead to terminal illnesses.
When combined with other typical forms of cancer treatment, some types of emerging therapy have been shown to increase the lifespan of patients with some of the most aggressive forms of mesothelioma, including pleural mesothelioma.
Photodynamic therapy, which uses light to target cancerous cells, is an emerging therapy that shows promise in this regard.
During an outpatient procedure, a patient will be given an injection to increase light sensitivity and will then undergo exposure to light energy that will affect tumors.
Currently only available in clinical trials, immunotherapy seeks to bolster a cancer patient’s immune system so that they are better able to withstand the deleterious effects of mesothelioma and to fight the disorder.
Immunotherapy is usually combined with other treatment methods, such as chemotherapy, and has shown promise in improving survival rates for patients with mesothelioma.
If clinical trials continue to see positive results, immunotherapy is poised to become an integral part of multimodal treatment approaches.
If you have been affected by mesothelioma or lung cancer contact Mesowatch today to discover what compensation options are available to you by way of trust funds and settlements with all liable parties for your asbestos exposure injuries.
This compensation includes damages for medical bills, wage losses, pain and suffering, loss of consortium, and more. The legal team will make all attempts to recover compensation as quickly as possible for you.